期刊文献+

人脐血间充质干细胞的生物学特性及治疗肺纤维化的作用机制 被引量:1

下载PDF
导出
摘要 肺纤维化是以大量的成纤维细胞聚集、细胞外基质沉积并伴有炎症和损伤所致组织结构破坏为特征。其病理特点包括肺组织间质细胞增殖、细胞外基质增生沉积及肺实质的重构,其发病率和病死率各不相同,严重性各异,但共同特点是缺少特异性治疗。过去对肺纤维化疾病的治疗仅限于非特异性抗炎、免疫抑制剂及糖皮质激素等,疗效尚不理想。随着肺纤维化发病机制研究的深入,细胞移植替代治疗成为近年来治疗肺纤维化研究热点。
出处 《河北联合大学学报(医学版)》 2012年第6期797-798,共2页 Journal of North China Coal Medical College
  • 相关文献

参考文献15

  • 1Friedenstein A J, Piatetzky - shapiro II , Petrakova KV. Osteogenesis in transplants of bone marrow cells [ J ]. Embryol exp Morph, 1966,16 (3) :581.
  • 2Jaiswal N, l-laynesworth S E, Caplan AI, et al. Osteogenic differentiation of purified, culture- expanded human mesenchymal stem cells in vitro [J]. Cell Biochem,1997,64(2) :295.
  • 3Erices A, Conget PA,Mingull JJ. Mesenchymal progenitor cells in hu- man umbilical cord blood [ J ]. Br J Haematology ,2000,109 : 235.
  • 4Leek OK, Kuo TK, Chen WM et al. Blood[ J]. 2004,103 : 1669 - 1675.
  • 5Hang EJ, Jeong JA, Hpng SH, et al. Blood[ J]. 2004,1669 - 1675.
  • 6Nakahata T,Ogawa M. Hemopoietic colony- forming cells in umbilical cord bloodwlth extensive Capability to generate mono and multipoten - tial hemopoietic progenitors[ J]. Clin Invest, 1982,70 : 1324.
  • 7迟作华,张洹.脐带血间充质干细胞的研究进展[J].国际生物医学工程杂志,2006,29(1):29-34. 被引量:23
  • 8Eun ji Gang,Seung Hyun Hong,Ju Ah Jeong,et al. Biochemical and Bi - ophysieal[ J]. Research Communicatiorts,2004,321:102.
  • 9Zavadil J, Buttinger EP. TGF - beta and epithelial to mesenchymal Tra - nsitions[J]. Oncogene,2005,24(37) :5764.
  • 10A danison IY, Bowden DH. The type 2 cell as progenitor of alveolar epithelial regeneration a cytodynam ic study in mice after exposure to oxygen[J]. Lab Invest ,1974,30( 1 ) :35.

二级参考文献4

共引文献22

同被引文献30

  • 1孔琪,秦川.肺纤维化的发病机制及关键靶点[J].国外医学(呼吸系统分册),2005,25(5):331-333. 被引量:34
  • 2De Miguel MP, Fuentes-Julian S, Bldzquez-Martinez A, et al. Immunosuppressive properties of mesenchymal stem cells: advances and applications[J]. Curr Mol Med, 2012, 12(5) :574-591.
  • 3Yi T, Song SU. Immunomodulatory properties of mesen ehymal stem cells and their therapeutic applications[J]. Arch Pharm Res,2012,35(2):213-221.
  • 4Akram KM, Lomas NJ,Forsyth NR,et al. Alveolar epi- thelial cells in idiopathic pulmonary fibrosis display up- regulation of TRAIL,DR4 and DR5 expression with sim- ultaneous preferential over-expression of pro-apoptotie marker p53[J]. Int J Clin Exp Pathol, 2014,7 (2) : 552-564.
  • 5Piguet PF, Collart MA, Grau GE, et al. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis[J]. J Exp Med, 1989,170 ( 3 ) : 655-663.
  • 6Kligerman SJ, Franks TJ, Galvin JR. From the radiologic pathology archives organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneu monia,and acute fibrinous and organizing pneumonia[J]. Radiographics,2013,33 (7) : 1951-1975.
  • 7Inamdar AC,Inamdar AA. Mesenchymal stem cell thera py in lung disorders: Pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell [J]. Exp Lung Res,2013,39(8) :315-327.
  • 8Qin ZH, Xu JF, Qu JM, et al. Intrapleural delivery of MSCs attenuates acute lung injury by paracrine/endocrine mech- anism[J]. J Cell Mol Med,2012,16(11):2745-2753.
  • 9Conese M, Carbone A, Castellani S, et al. Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases [J]. Cells Tissues Organs,2013,197(6):445-473.
  • 10Gazdhar A, Susuri N, Hostettler K, et al. HGF expressing stem cells in usual interstitial pneumonia originate from the bone marrow and are antifibrotic [J]. PLoS One, 2013,8(6):e65453.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部